Bernard H Ramsahoye
Overview
Explore the profile of Bernard H Ramsahoye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
743
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Redl E, Sheibani-Tezerji R, de Jesus Cardona C, Hamminger P, Timelthaler G, Hassler M, et al.
Life Sci Alliance
. 2020 Dec;
4(2).
PMID: 33310759
Malignant transformation depends on genetic and epigenetic events that result in a burst of deregulated gene expression and chromatin changes. To dissect the sequence of events in this process, we...
2.
Handley M, Reddy K, Wills J, Rosser E, Kamath A, Halachev M, et al.
PLoS Genet
. 2019 Mar;
15(3):e1007605.
PMID: 30856165
Typical Martsolf syndrome is characterized by congenital cataracts, postnatal microcephaly, developmental delay, hypotonia, short stature and biallelic hypomorphic mutations in either RAB3GAP1 or RAB3GAP2. Genetic analysis of 85 unrelated "mutation...
3.
Lagger S, Connelly J, Schweikert G, Webb S, Selfridge J, Ramsahoye B, et al.
PLoS Genet
. 2017 May;
13(5):e1006793.
PMID: 28498846
Mutations in the gene encoding the methyl-CG binding protein MeCP2 cause several neurological disorders including Rett syndrome. The di-nucleotide methyl-CG (mCG) is the classical MeCP2 DNA recognition sequence, but additional...
4.
Bisling K, Brewin J, McGovern A, Horne G, Rider T, Stewart H, et al.
Leuk Lymphoma
. 2013 Jun;
55(3):711-4.
PMID: 23741974
No abstract available.
5.
Reddington J, Perricone S, Nestor C, Reichmann J, Youngson N, Suzuki M, et al.
Genome Biol
. 2013 Mar;
14(3):R25.
PMID: 23531360
Background: DNA methylation and the Polycomb repression system are epigenetic mechanisms that play important roles in maintaining transcriptional repression. Recent evidence suggests that DNA methylation can attenuate the binding of...
6.
Sproul D, Kitchen R, Nestor C, Dixon J, Sims A, Harrison D, et al.
Genome Biol
. 2012 Oct;
13(10):R84.
PMID: 23034185
Background: Aberrant CpG island promoter DNA hypermethylation is frequently observed in cancer and is believed to contribute to tumor progression by silencing the expression of tumor suppressor genes. Previously, we...
7.
Latham T, Mackay L, Sproul D, Karim M, Culley J, Harrison D, et al.
Nucleic Acids Res
. 2012 Feb;
40(11):4794-803.
PMID: 22323521
Chemical inhibitors of histone deacetylase (HDAC) activity are used as experimental tools to induce histone hyperacetylation and deregulate gene transcription, but it is not known whether the inhibition of HDACs...
8.
Nimmo E, Prendergast J, Aldhous M, Kennedy N, Henderson P, Drummond H, et al.
Inflamm Bowel Dis
. 2011 Oct;
18(5):889-99.
PMID: 22021194
Background: Germline variation in the 71 Crohn's disease (CD) loci implicated by genome-wide association studies (GWAS) only accounts for approximately 25% of estimated heritability. The contribution of epigenetic alterations to...
9.
Sproul D, Nestor C, Culley J, Dickson J, Dixon J, Harrison D, et al.
Proc Natl Acad Sci U S A
. 2011 Mar;
108(11):4364-9.
PMID: 21368160
Aberrant promoter hypermethylation is frequently observed in cancer. The potential for this mechanism to contribute to tumor development depends on whether the genes affected are repressed because of their methylation....
10.
Dodge J, Ramsahoye B, Wo Z, Okano M, Li E
Gene
. 2002 May;
289(1-2):41-8.
PMID: 12036582
DNA methyltransferases, Dnmt3a and Dnmt3b, are required for de novo methylation in embryonic stem (ES) cells and postimplantation embryos. However, the mechanism of de novo methylation is largely unknown. In...